| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
L | | IP | CI | V/S | Cutaquig 165 mg/ml | | 66.50 | 88.75 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cutaquig 165 mg/ml | | 133.01 | 161.05 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cutaquig 165 mg/ml | | 266.02 | 305.75 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cutaquig 165 mg/ml | | 532.04 | 595.05 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cutaquig 165 mg/ml | 10 | 665.05 | 739.70 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cutaquig 165 mg/ml | 10 | 1330.10 | 1463.00 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cutaquig 165 mg/ml | 10 | 2660.20 | 2909.55 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cutaquig 165 mg/ml | 10 | 5320.40 | 5766.55 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cuvitru 200 mg/ml | 5 ml | 65.42 | 87.55 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cuvitru 200 mg/ml | 10 ml | 130.84 | 158.70 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cuvitru 200 mg/ml | 20 ml | 261.68 | 301.00 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cuvitru 200 mg/ml | 40 ml | 523.36 | 585.60 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | Cuvitru 200 mg/ml | 50 ml | 654.20 | 727.90 | 10 % | | Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | HyQvia 100 mg/ml | 1 + | 165.68 | 196.60 | 10 % | | Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | HyQvia 100 mg/ml | 1 + | 331.35 | 376.80 | 10 % | | Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | HyQvia 100 mg/ml | 1 + | 662.71 | 737.15 | 10 % | | Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | HyQvia 100 mg/ml | 1 + | 1325.41 | 1457.90 | 10 % | | Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | CI | V/S | HyQvia 100 mg/ml | 1 + | 1988.12 | 2178.60 | 10 % | | Infusionslösung zur subkutanen Anwendung: Immunoglobulinum Humanum Normale 100 mg/ml | Takeda Pharma AG | B / SL | FB | | G |  |
L | | IP | | V/S | Hizentra | Durchstechflasche(n) à 5 ml | 65.54 | 87.70 | 10 % | | Injektionslösung zur s.c. Anwendung: Immunoglobulinum Humanum Normale 200 mg/ml | CSL Behring AG | B / SL | FB | | G |  |
L | | IP | | V/S | Hizentra | Durchstechflasche(n) à 10 ml | 131.08 | 158.95 | 10 % | | Injektionslösung zur s.c. Anwendung: Immunoglobulinum Humanum Normale 200 mg/ml | CSL Behring AG | B / SL | FB | | G |  |
L | | IP | | V/S | Hizentra | Durchstechflasche(n) à 20 ml | 262.16 | 301.55 | 10 % | | Injektionslösung zur s.c. Anwendung: Immunoglobulinum Humanum Normale 200 mg/ml | CSL Behring AG | B / SL | FB | | G |  |
L | | IP | | V/S | Hizentra | Durchstechflasche(n) à 50 ml | 655.40 | 729.20 | 10 % | | Injektionslösung zur s.c. Anwendung: Immunoglobulinum Humanum Normale 200 mg/ml | CSL Behring AG | B / SL | FB | | G |  |
| | IP | CI | V/S | Cutaquig 165 mg/ml | 20 | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | CI | V/S | Cutaquig 165 mg/ml | 20 | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | CI | V/S | Cutaquig 165 mg/ml | 20 | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | CI | V/S | Cutaquig 165 mg/ml | 20 | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 6 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 10 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 12 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 20 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 24 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 48 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 10 x 6 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 10 x 10 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 20 x 6 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 10 x 12 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 20 x 10 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 10 x 20 ml | 2052.60 | 2312.70 | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 20 x 12 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 10 x 24 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 20 x 20 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 20 x 24 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 10 x 48 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |
| | IP | | V/S | Gammanorm | 20 x 48 ml | PR | PR | k.A. | | Injection solution: Immunoglobulinum Humanum Normale 165 mg/ml | Octapharma AG | B | FB | | G |  |